SCHEMBL24709136

SCHEMBL24709136

CNCc1ccc(-c2cc(-c3nc(-c4ccc(SC(C)C)cc4)cnc3N)on2)cc1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATR Q13535 20/20 0.71
ATM Q13315 9/20 0.71
PRKDC P78527 5/20 0.71
GSK3B P49841 2/20 0.71
JAK2 O60674 1/20 0.71
ABL1 P00519 1/20 0.71
KIT P10721 1/20 0.71
SERPINA2 P20848 1/20 0.71
PIK3R1 P27986 1/20 0.71
FLT4 P35916 1/20 0.71
FLT3 P36888 1/20 0.71
PIK3CA P42336 1/20 0.71
MTOR P42345 1/20 0.71
SYK P43405 1/20 0.71
GSK3A P49840 1/20 0.71
MAP3K9 P80192 1/20 0.71
KCNH2 Q12809 1/20 0.71
MERTK Q12866 1/20 0.71
DYRK2 Q92630 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25042558 0.91 ATR (0.59) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433151 0.90 ATR (0.61) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433163 0.89 ATR (0.65) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433315 0.89 ATR (0.65) ATRATMPRKDCGSK3BJAK2
SCHEMBL19672802 0.89 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL25042829 0.88 ATR (0.56) ATRATMPRKDCGSK3BJAK2
SCHEMBL25042544 0.88 ATR (0.56) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433277 0.87 ATR (0.65) ATRATMPRKDCGSK3BJAK2
SCHEMBL15120108 0.87 ATR (0.75) ATRATMPRKDCGSK3BJAK2
SCHEMBL25042628 0.87 ATR (0.58) ATRATMPRKDCGSK3BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022213204-A9 CARBOXAMIDE PYROLOPYRAZINE AND PYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF MYT1 AND USE THEREOF IN THE TREATMENT OF CANCER REPARE THERAPEUTICS INC. (CA) 2023-11-16 WO disclosed
WO-2023166077-A1 COMBINATION OF A CTPS1 INHIBITOR AND A ATR INHIBITOR IN CANCER THERAPY STEP PHARMA S.A.S. (FR) 2023-09-07 WO disclosed
WO-2023016525-A1 COMPOUND AS ATR KINASE INHIBITOR 苏州爱科百发生物医药技术有限公司 2023-02-16 WO disclosed
WO-2022213204-A1 COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2022-10-13 WO disclosed